what's in glp-1 receptor agonists for individualized treatment of type 2 diabetes mellitus The GLP-1 Agonists and Obesity:

Multiple primary melanoma with the Meyerson phenomenon in a young patient

Treatment decisions should always be made in consultation with a qualified healthcare provider based on an individual's medical history, health goals, and personal circumstances.

Getting into the Bridge program requires that you have a doctor, nurse practitioner or physician assistant prescribe an eligible GLP-1-based medication and attest to the Medicare program that you qualify under Bridges prior authorization criteria

We have access to personal trainers, InBody technology to monitor body composition/weight trends, and personalized plans guided by your treatment provider